Intensity-Modulated Reirradiation Therapy With Nivolumab in Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma

Post time 3 day(s) ago

journal：JAMA Oncology

Authors：Nabil F. Saba; Stuart J. Wong; Tahseen Nasti; Ashley Alesia McCook-Veal; Mark W. McDonald; William A. Stokes; Allyson M. Anderson; Asari Ekpenyong; Manali Rupji; Marin Abousaud; Soumon Rudra; James E. Bates; Jill S. Remick; Nikhil P. Joshi; Neil M. Woody; Musaddiq Awan; Jessica L. Geiger; Aditya Shreenivas; Julia Samsa; Matthew Christopher Ward; Nicole C. Schmitt; Mihir R. Patel; Kristin A. Higgins; Yong Teng; Conor E. Steuer; Dong M. Shin; Yuan Liu; Rafi Ahmed; Shlomo A. Koyfman

Published date：--

DOI：10.1001/jamaoncol.2024.1143

PDF link：https://jamanetwork.com/journals ... 715728140.39869.pdf

Article link：http://dx.doi.org/10.1001/jamaoncol.2024.1143

Article Source：American Medical Association (AMA)。

Remark：

Post time 3 day(s) ago

: This post has been completed
Completed attachments will be deleted within 24 hours.

[JAMA] Intensity-Modulated Reirradiation Therapy With Nivolumab in Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[JAMA] Intensity-Modulated Reirradiation Therapy With Nivolumab in Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma Copy